The cell-free DNA (cfDNA) blood collection tube market is ripe with opportunities driven by the rise in lifestyle-related ...

A new blood test measures cell-free DNA to detect ALS early and distinguish it from other neurological disorders.

Fetuses at high risk for cystic fibrosis may be detected by screening of pregnant mothers using reflex to cell-free DNA analysis.

New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis of ALS by measuring cell-free DNA.

Elegen’s Gen II DNA Synthesizer Platform—built for the AI era of genetic medicine—delivers long, complex DNA at unmatched speed, quality, and scale.

A new study may finally change how amyotrophic lateral sclerosis (ALS) is diagnosed. Scientists from UCLA Health and the ...

Natera Inc. is conducting a study titled ‘EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND).’ The study aims to develop and validate a single-gene Non-Invasive Prenatal ...

Researchers developed a cell-free DNA blood test that accurately distinguishes ALS from other neurological diseases and tracks progression.

The company aims to broadly offer DNA from the fully-automated, miniaturized, high-throughput, clinical-ready DNA production platform later next year Elegen, a global leader in next-generation cell-fr ...

BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased ...